-
Quercetin and Nano-Derivatives: Potential and Challenges in Cancer Therapy
24 May 2025 12:50 GMT
… target EMT.84 In lung cancer, QUE inhibits metastasis … of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate … translocation of β-catenin in lung cancer cell line. Nutr Cancer. … in non-small cell lung cancer. Biomed Pharmacother. 2023 …
-
Geriatric Nutritional Risk Index (GNRI) and Prognostic Nutritional Index (PNI) Before Treatment as the Predictive Indicators for Bone Metastasis in Prostate Cancer Patients
24 May 2025 12:50 GMT
… in men worldwide after lung cancer.2 Both the … , et al. Advanced lung cancer inflammation index combined with geriatric … -resistant prostate cancer receiving docetaxel. Front Pharmacol. 2020; … for non-small cell lung cancer patients with bone metastasis. …
-
GMCL1 Controls 53BP1 Stability and Modulates Paclitaxel Sensitivity in Cancer
23 May 2025 20:41 GMT
… .g., paclitaxel and docetaxel), which disrupt spindle formation … dataset, including cabazitaxel, docetaxel, and paclitaxel, integrating … ;or docetaxel (Figure 3A-C). In contrast, lung cancer cell … that nearly half of lung cancers harbor p53 mutations30, we …
-
ASCO 2025 Preview: Practice-Changing Trials to Watch
23 May 2025 17:31 GMT
… , leucovorin, oxaliplatin, and docetaxel, improved event-free survival … new on the horizon.”
Lung Cancer
This study supports lurbinectedin … extensive-stage small cell lung cancer (SCLC), offering a … resectable non–small cell lung cancer, with event-free …
-
Six Abstracts of Kelun-Biotech’s Clinical Studies Published at the 2025 ASCO Annual Meeting
23 May 2025 15:23 GMT
… EGFR)-mutated non-small-cell lung cancer (NSCLC): Results from the … outcomes compare d to docetaxel: confirmed objective response rate … 30 CDT (Abstract #8529: Lung Cancer – Non-Small Cell Metastatic) … for marketing in a lung cancer indication. In addition, …
-
RWJBarnabas Health and Rutgers Cancer Institute to Present Practice-Changing Research at 2025 ASCO Annual Meeting
23 May 2025 02:57 GMT
… mutant oligometastatic non small cell lung cancer treated with combination definitive chemoradiotherapy … of intravesical sequential gemcitabine and docetaxel.
N/A
N…
-
Astellas And Pfizer's XTANDITM (Enzalutamide) Shows Long-Term Overall Survival In Metastatic Hormone-Sensitive Prostate Cancer
22 May 2025 23:03 GMT
… volume disease, no prior docetaxel use, and synchronous disease … suppression with or without docetaxel – in mHSPC will … received recent treatment with docetaxel for mHSPC, but whose … and thoracic cancers, which includes lung cancer. Driven by science, we …
-
BeiGene Presents Pioneering Cancer Research at ASCO 2025 – Redefining Treatment Across Hematology and Solid Tumors
22 May 2025 10:08 GMT
… BGB-A445, in combination with docetaxel or BGB-15025, an HPK1 …
Additional Abstracts
Clinical Trial Diversity
Lung cancer enrollment of demographic subgroups in … : 216
Poster Presentation
Session Title: Lung Cancer - Non-Small Cell Local …
-
Bayer Highlights New Data from Oncology and Women’s Health Portfolios at 2025 ASCO Annual Meeting
21 May 2025 12:08 GMT
… , including for prostate and lung cancer. This year’s ASCO … HER2-mutant non-small cell lung cancer (NSCLC), Bayer is … patients who received NUBEQA with docetaxel included febrile neutropenia (6% … patients with non-small cell lung cancer (NSCLC) harboring human …
-
AstraZeneca’s record seventh year of plenary data at ASCO furthers ambition to redefine breast cancer care and transform outcomes in gastric cancer
21 May 2025 11:09 GMT
… EGFR-mutated non-small cell lung cancer (NSCLC) (Oral Abstract … advanced non-small cell lung cancer (aNSCLC).
Abstract # … leucovorin, oxaliplatin, and docetaxel chemotherapy (FLOT) in resectable … resectable non-small-cell lung cancer (NSCLC): Updated outcomes …
About
© 1995-2025